Sanuwave Health, a company out of Alpharetta, GA that develops noninvasive devices used in regenerative medicine, has received a U.S. patent for its acoustic shock-wave technology. Treatments using the technology apply shock waves, which cause micro-injury to the targeted area of the body, stimulating growth factors and resulting in an increase in new blood vessel formation. Patent 7,985,189, which is titled “Method For Using Acoustic Shock Waves in the Treatment of Medical Conditions,” covers the treatment of a variety of orthopedic conditions, such as tendinitis, osteoporosis, and stress fractures.
The patent will protect intellectual property related to the company’s Pulsed Acoustic Cellular Expression (PACE) and orthoPACE technology, which are used to treat various musculoskeletal conditions. According to the manufacturer, orthopedic, sports medicine, and trauma conditions that are treated with the technology have documented success rates that are at least as good as analogous surgical procedures.
Patent information: Method for using acoustic shock waves in the treatment of medical conditions